Drugsupdate.com is up for sale. To own one of the most recognized online brands by doctors in India with millions of visitors - click here.

logo image

Benfotiamine information from DrugsUpdate  

See Available Brands of Benfotiamine in India

Benfotiamine (rINN, or S-benzoylthiamine O-monophoshate) is a synthetic S-acyl derivative of thiamine (vitamine B1). After absorption, benfotiamine can be dephosphorylated by cells bearing an ecto-alkaline phosphatase to the lipid-soluble S-benzoylthiamine. Benfotiamine should not be confused with allithiamine, a naturally occurring thiamine disulfide derivative with a distinct pharmacological profile.

Pharmacodynamics

Pharmacokinetics

Benfotiamine is an allithiamine that boosts Advanced Glycation Endproduct (AGE)-inhibiting thiamine pyrophosphate and cell-shielding transketolase activity.

Benfotiamine Indications / Benfotiamine Uses

Information Not Available

Benfotiamine Adverse Reactions / Benfotiamine Side Effects

Information Not Available

Precautions

Information Not Available

Special Precautions

Information Not Available

Other Drug Interactions

Information Not Available

Other Interactions

Information Not Available

Dosage

Oral Diabetic neuropathy, Alcoholic neuropathy Adult: 100 mg 4 times daily.

Food(before/after)

Information Not Available

List of Contraindications

Benfotiamine and Pregnancy

Information Not Available

Benfotiamine and Lactation

Information Not Available

Benfotiamine and Children

Information Not Available

Benfotiamine and Geriatic

Information Not Available

Benfotiamine and Other Contraindications

Hypersentivity

Storage

Information Not Available

Lab interference

Information Not Available

© 2011-2019 DrugsUpdate.com. Disclaimer | Site Map

Feedback
  • Companies that own platforms will own the market
  • Trusted and recognized by all Doctors
  • Access to Millions of Visitors instantly.
  • Companies that own platforms will own the market
  • Trusted and recognized by all Doctors
  • Access to Millions of Visitors instantly.